Researcher.Life Logo

Neurotherapeutics : Impact Factor & More

eISSN: 1878-7479pISSN: 1933-7213

Key Metrics

CiteScore
10
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Pharmacology
SNIP
1.75
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neurotherapeutics

Neurotherapeutics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SPRINGER
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2004
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Neurotherapeutics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neurotherapeutics

Involvement of trimethylamine N-oxide in major depressive disorder via astrocytic d-Serine dysregulation.
  • 15 Apr 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Neuromodulation of the central nervous system for facial pain.
  • 11 Apr 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
RNA-binding protein MBNL2 mitigates neuropathic pain after chemotherapy through destabilizing CCR2 expression in primary sensory neurons.
  • 11 Apr 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
The wearing-off effect with natalizumab: Back to the drawing board.
  • 10 Apr 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Restoring Theta-Gamma coupling in Alzheimer's disease: Toward network-based neuromodulation.
  • 9 Apr 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Identification of vital sign trajectory phenotypes and treatment response heterogeneity in critically ill patients with ischemic stroke: A multicenter study with external validation.
  • 8 Apr 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Involvement of trimethylamine N-oxide in major depressive disorder via astrocytic d-Serine dysregulation.
  • 15 Apr 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Neuromodulation of the central nervous system for facial pain.
  • 11 Apr 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
RNA-binding protein MBNL2 mitigates neuropathic pain after chemotherapy through destabilizing CCR2 expression in primary sensory neurons.
  • 11 Apr 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
The wearing-off effect with natalizumab: Back to the drawing board.
  • 10 Apr 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Restoring Theta-Gamma coupling in Alzheimer's disease: Toward network-based neuromodulation.
  • 9 Apr 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Identification of vital sign trajectory phenotypes and treatment response heterogeneity in critically ill patients with ischemic stroke: A multicenter study with external validation.
  • 8 Apr 2026
  • Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

FAQs on Neurotherapeutics